Meridian Wealth Partners’s Genmab GMAB Stock Holding History

Meridian Wealth Partners’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-115	Closed	-$4K	–	558
2021 Q1	$4K	Buy	+115	New	+$4.33K	﹤0.01%	768

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Meridian Wealth Partners's GMAB Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Genmab (GMAB) in Q2 2021, closing a stake of 115 shares — an estimated $4K sold.

Meridian Wealth Partners first reported a position in GMAB in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 212 funds tracked by Wall St. Rank hold GMAB as of Q2 2021.

Meridian Wealth Partners reported no remaining Genmab position as of Q2 2021 after selling out during the quarter.
Meridian Wealth Partners sold 115 Genmab shares in Q2 2021, an estimated $4K.
Meridian Wealth Partners first reported a position in Genmab in Q1 2021 and held it in 1 quarter.
Meridian Wealth Partners's Genmab position peaked at $4K in Q1 2021.
212 funds tracked by Wall St. Rank held Genmab as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.